Ontvang nu dagelijks onze kooptips!

word abonnee
IEX 25 jaar
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
Markt vandaag Koersen Forum Premium IEX Expert
Home  /   Forum   /   Acacia Pharma   /   Lancering Barhemsys H1 19 ?

Acacia Pharma« Terug naar discussie overzicht

Lancering Barhemsys H1 19 ?

Volgen
3.795 Posts
Pagina: «« 1 ... 18 19 20 21 22 ... 190 »» | Laatste | Omlaag ↓
  3. [verwijderd] 8 januari 2019 17:22
    quote:

    For a fistful of dollars schreef op 8 januari 2019 16:43:

    What is the influence of next week's vote (15th of January) on the Brexit for Acacia Pharma, being registered in England ? If we move towards a no deal Brexit, then all shares of GB listed companies may head downwards...
    It seems you only post when we go down. And everytime these vague kinds of negative messages. But if shorting is your way, thats fine. But placing non relevant stupid messages here to get your profit is not.

    So why is this a stupid remark?

    Acacia only targets the.... drumroll....US market.
  4. Derwing 8 januari 2019 17:41
    quote:

    Madebeliefje schreef op 8 januari 2019 17:22:

    [...]
    It seems you only post when we go down. And everytime these vague kinds of negative messages. But if shorting is your way, thats fine. But placing non relevant stupid messages here to get your profit is not.

    So why is this a stupid remark?

    Acacia only targets the.... drumroll....US market.
    Yes I dont think Acacia should get much trouble for that. The US government shutdown on FDA approvals did cross my mind for a second though. But current applications should be uneffected by the shutdown.
  6. [verwijderd] 8 januari 2019 21:15
    quote:

    For a fistful of dollars schreef op 8 januari 2019 16:43:

    What is the influence of next week's vote (15th of January) on the Brexit for Acacia Pharma, being registered in England ? If we move towards a no deal Brexit, then all shares of GB listed companies may head downwards...
    It would not be logical or reasonable for the Brexit vote (on 15 January) to have any effect on the stock price of Acacia Pharma. The Brexit vote has nothing to do with the quality of the product and pipeline of Acacia Pharma. What is important for Acacia Pharma is the awaited FDA decision. It is possible that somebody might use the Brexit vote to manipulate price movement in the stock market. But I don't think that it will have any long lasting effect on Acacia Pharma. I have not been able to find any news in the public domain that can explain the present low value of the stock price of Acacia Pharma. If people are selling the stock because of the upcoming Brexit vote, then I think that such line of action is unreasonable. The FDA decision can come any day from now--very unexpectedly. So, one has to be careful.
  7. Derwing 8 januari 2019 21:51
    quote:

    Investor68 schreef op 8 januari 2019 21:15:

    [...]

    It would not be logical or reasonable for the Brexit vote (on 15 January) to have any effect on the stock price of Acacia Pharma. The Brexit vote has nothing to do with the quality of the product and pipeline of Acacia Pharma. What is important for Acacia Pharma is the awaited FDA decision. It is possible that somebody might use the Brexit vote to manipulate price movement in the stock market. But I don't think that it will have any long lasting effect on Acacia Pharma. I have not been able to find any news in the public domain that can explain the present low value of the stock price of Acacia Pharma. If people are selling the stock because of the upcoming Brexit vote, then I think that such line of action is unreasonable. The FDA decision can come any day from now--very unexpectedly. So, one has to be careful.
    I think most investors already assume that the FDA will aprove Barhemsys. In that sense, an approval on the 5th of may or before should not increase the stock price either. Yet it will, just like a mere delay in the approval caused the stock to drop by 70%. For barely any stock nowadays does the value truely represent the intrinsic company value. Stocks that pay out dividends are typically getting close, as nobody can argue with the hard cash it pays off. But all stocks are somehow effected by factors that should have absolutely no effect on the company.

    As for Acacia Pharma, the expected year at which it will assume to make profit is 2022/2023. Athough it is a few more years from now, it is within a reasonable timeframe. If you believe in the company and the product then it doesn't matter what happens to the Brexit, the trade war or the delayed FDA approval. After 2023, the Acacia stock price will be based on the money they are making.
  12. Derwing 16 januari 2019 08:14
    Vanwege de brexit?
    Vooralsnog lijkt het erop dat we gaan openen rond 1.6, maar wel kans dat we verder gaan wegzakken komende weken. We liggen gewoon weer ongeveer op de dalenende trendlijn die al sinds de IPO is ingezet (als je de pieken en dalen eruit haalt gaat je lijn linear een klein beetje naar beneden).
  15. Derwing 17 januari 2019 07:52
    Ik had eergister 12,5% van mijn aandelen verkocht, met het plan die rond 1.4 weer terug te kopen. Helaas staat er nu 13.000 bestens in de bied...mooie timing weer. We gaan vandaag richting de 1.7 in ieder geval. Ben benieuwd of dit weer een tijdelijke opleving is, of dat het tij nu aan het keren is.
3.795 Posts
Pagina: «« 1 ... 18 19 20 21 22 ... 190 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Markt Vandaag

Stijgers

instrument koers absoluut verschil relatief verschil
B&S Group SA 4,395 +0,34 +8,25%
Galapagos 25,380 +1,42 +5,93%
EBUSCO HOLDING 0,925 +0,05 +5,16%
ALLFUNDS GROUP 5,430 +0,27 +5,13%
BESI 112,800 +5,30 +4,93%
THEON INTERNAT 10,340 +0,48 +4,87%
RENEWI 7,150 +0,24 +3,47%
UNILEVER PLC 56,440 +1,88 +3,45%
RELX 44,820 +1,42 +3,27%
FASTNED 21,300 +0,65 +3,15%
Pharming 0,716 +0,02 +3,02%
Wolters Kluwer 157,950 +4,60 +3,00%
WDP 20,720 +0,60 +2,98%
UMG 22,580 +0,63 +2,87%
CTP 15,100 +0,40 +2,72%
DSM FIRMENICH AG 107,250 +2,40 +2,29%
INPOST 17,210 +0,35 +2,08%
SIGNIFY NV 21,740 +0,44 +2,07%
IMCD 140,150 +2,80 +2,04%
Eurocommercial Properties 23,300 +0,45 +1,97%
Fagron 18,620 +0,34 +1,86%
ADYEN NV 1.290,400 +23,40 +1,85%
ASML 642,100 +10,60 +1,68%
ASMI 504,600 +8,20 +1,65%
Ahold Delhaize 32,830 +0,52 +1,61%
AEX 879,80 +13,67 +1,58%
Kendrion 10,900 +0,16 +1,49%
JDE PEET'S 18,600 +0,23 +1,25%
OCI 11,315 +0,13 +1,16%
Heineken 70,640 +0,76 +1,09%
ACOMO 17,640 +0,18 +1,03%
Sif Holding 12,220 +0,12 +0,99%
AMX 866,26 +8,37 +0,98%
NX FILTRATION 4,240 +0,04 +0,95%
Avantium 2,170 +0,02 +0,93%
EXOR NV 95,200 +0,85 +0,90%
Brunel 8,470 +0,07 +0,83%
ASCX 1.183,15 +9,48 +0,81%
RANDSTAD NV 40,610 +0,31 +0,77%
Nedap N.V. 52,400 +0,40 +0,77%
Philips Koninklijke 25,220 +0,19 +0,76%
Sligro 10,660 +0,08 +0,76%
Corbion 21,980 +0,16 +0,73%
Arcadis 62,200 +0,45 +0,73%
AALBERTS NV 34,100 +0,22 +0,65%
ASR Nederland 45,130 +0,29 +0,65%
Vastned 24,250 +0,15 +0,62%
Wereldhave 14,120 +0,08 +0,57%
KPN 3,620 +0,02 +0,56%
Aegon 5,960 +0,03 +0,51%
TomTom 5,200 +0,03 +0,48%
Akzo Nobel 55,880 +0,26 +0,47%
ArcelorMittal 23,990 +0,08 +0,33%
SHELL PLC 31,610 +0,09 +0,27%
NSI 19,700 +0,04 +0,20%
Accsys 0,555 +0,00 +0,18%
HEIJMANS KON 27,950 +0,05 +0,18%
Fugro 16,900 +0,03 +0,18%
AMG Critical Materials N.V. 14,980 +0,01 +0,07%
PostNL 1,009 0,00 0,00%

Dalers

instrument koers absoluut verschil relatief verschil
EBUSCO (RIGHT) 0,000 -0,16 -99,81%
SBM Offshore 17,720 -0,30 -1,66%
CM.COM 6,000 -0,10 -1,64%
JUST EAT TAKEAWAY 14,010 -0,23 -1,58%
Alfen N.V. 11,245 -0,17 -1,45%
Vopak 45,100 -0,60 -1,31%
Flow Traders 21,380 -0,28 -1,29%
BAM 4,010 -0,05 -1,23%
ING 14,652 -0,17 -1,16%
ForFarmers 3,280 -0,03 -0,91%
Van Lanschot Kempen NV 43,100 -0,35 -0,81%
ABN AMRO BANK N.V. 14,735 -0,12 -0,77%
AZERION 1,266 -0,01 -0,63%
Air France-KLM 7,358 -0,05 -0,62%
TKH 31,720 -0,18 -0,56%
NN Group 44,640 -0,20 -0,45%
Basic-Fit 21,500 -0,08 -0,37%
PROSUS 37,970 -0,13 -0,35%
Aperam 27,560 -0,06 -0,22%
vlag naam koers verschil relatief verschil
AEX 879,80 +13,67 +1,58%
AEX GR 3.450,86 +53,61 +1,58%
Germany40^ 19.354,60 +208,43 +1,09%
FTSE 100 8.262,08 +112,81 +1,38%
EURO50 4.797,55 0,00 0,00%
US30^ 44.302,90 0,00 0,00%
Nasd100^ 20.778,50 0,00 0,00%
US500^ 5.965,55 0,00 0,00%
Japan225^ 38.598,50 0,00 0,00%
VD-NEW 16,06 -0,99 -5,82%
#/^ Index indications calculated real time, zie disclaimer